DeutschNewstral
Article
bizjournals.com on 2020-02-03 14:42
United Therapeutics gets disappointing news on cancer therapy
Related news
- United Therapeutics gets disappointing news on cancer therapybizjournals.com
- United Therapeutics gets another FDA approval for pulmonary hypertension therapybizjournals.com
FDA OKs United Therapeutics’ cancer drugthedailyrecord.com- United Therapeutics gets boost from new drugbizjournals.com
- United Therapeutics gets one step closer to another product approvalbizjournals.com
- United Therapeutics profit soarsthedailyrecord.com
- United Therapeutics gets good news — and stock boost — from drug candidatebizjournals.com
- United Therapeutics gets long-awaited FDA approval as competitor Liquidia takes stock hitbizjournals.com
- United Therapeutics sues Vanderbilt Universitybizjournals.com
- United Therapeutics to acquire competitor pharmaceutical companybizjournals.com
- United Therapeutics settles infringement case against Sandozbizjournals.com
- United Therapeutics sued by generic drug competitorsbizjournals.com
- United Therapeutics scores another FDA approvalbizjournals.com
- United Therapeutics settles federal anti-kickbacks case for $210Mbizjournals.com
- United Therapeutics seeks to dismiss sexual harassment lawsuitbizjournals.com
- United Therapeutics’ 2020 plan: ‘No fewer’ than 3 FDA approvalsbizjournals.com
- United Therapeutics sues North Carolina competitor for patent infringementbizjournals.com